Pretreatment | Vehicle | Vehicle | Vehicle | Vehicle | OMP | Ranitidine | Pyrilamine |
---|---|---|---|---|---|---|---|
Intravenous treatment | Saline | Pentagastrin | Saline | Pentagastrin | Pentagastrin | Pentagastrin | Pentagastrin |
A-ASA | − | − | + | + | + | + | + |
Macroscopic injury score [n] | 0.5 (0.5) [4] | 1.3 (0.7) [3] | 33.8 (6.3) [8] | 7.3 (3.5)1-150 [6] | 17.8 (3.9)1-150[6] | 45.7 (8.6)† ‡ § [6] | 6.8 (2.9)1-150 [5] |
Histological injury score [n] | 21.6 (12.0) [3] | 156.5 (12.0) [8] | 56.5 (9.1)1-150 [6] | 88.3 (20.8)1-150 [6] | 152.8 (16.8)† ‡ §[6] | 90.5 (16.6)1-150 [5] | |
% Surface injury | 9.1 (5.0) | 10.2 (2.3) | 12.1 (1.4) | 17.6 (4.9) | 10.0 (2.5)‡ | 11.6 (3.1) | |
% Shallow injury | 6.3 (3.5) | 42.7 (4.8) | 19.8 (4.5)1-150 | 12.3 (7.0)1-150 | 26.3 (5.3)1-150 | 14.8 (4.7)1-150 | |
% Deep injury | 0.0 (0.0) | 21.3 (5.5) | 3.2 (1.9)1-150 | 8.0 (2.7) | 29.8 (7.3)† ‡ | 16.4 (4.3)† |
Values expressed as mean (SEM) obtained from the number of rats indicated in square brackets.
↵1-150 p<0.05 v vehicle + saline + A-ASA, †p<0.05 v vehicle + pentagastrin + A-ASA,‡ p<0.05 v OMP + pentagastrin + A-ASA, §p<0.05 v pyrilamine + pentagastrin + A-ASA among five groups treated with A-ASA.
OMP, omeprazole.